SCHEMBL6804932

SCHEMBL6804932

CC(F)=Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
TSHR P16473 1/20 0.54
AKR1C3 P42330 1/20 0.54
FBP1 P09467 1/20 0.48
KDM1A O60341 1/20 0.45
RECQL P46063 1/20 0.45
MTNR1A P48039 2/20 0.44
MTNR1B P49286 2/20 0.44
HTT P42858 1/20 0.44
GLA P06280 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
AKR1C1 Q04828 1/20 0.41
ESR1 P03372 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14518618 1.00 ALDH1A1 (0.54) ALDH1A1TSHRAKR1C3FBP1KDM1A
SCHEMBL7633159 1.00 ALDH1A1 (0.54) ALDH1A1TSHRAKR1C3FBP1KDM1A
SCHEMBL7150972 0.78 AKR1C3 (0.59) ALDH1A1TSHRAKR1C3FBP1KDM1A
SCHEMBL15709853 0.78 ALDH1A1 (0.46) ALDH1A1TSHRAKR1C3FBP1AKR1C1
SCHEMBL19712515 0.78 ALDH1A1 (0.46) ALDH1A1TSHRAKR1C3FBP1AKR1C1
SCHEMBL23458002 0.78 AKR1C3 (0.73) ALDH1A1TSHRAKR1C3FBP1KDM1A
SCHEMBL466536 0.78 ALDH1A1 (0.46) ALDH1A1TSHRAKR1C3FBP1AKR1C1
SCHEMBL6433811 0.78 AKR1C3 (0.73) ALDH1A1TSHRAKR1C3FBP1KDM1A
SCHEMBL60657 0.78 ALDH1A1 (0.58) ALDH1A1TSHRAKR1C3FBP1KDM1A
SCHEMBL598776 0.78 ALDH1A1 (0.58) ALDH1A1TSHRAKR1C3FBP1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6723743-B1 TREATING PATIENT SUFFERING FROM RHEUMATOID ARTHRITIS, PSORIASIS, BRONCHIAL ASTHMA, ALZHEIMER'S DISEASE, MYOCARDIAL INFARCTION OR ATHEROSCLEROSIS NEUROGEN CORPORATION 2004-04-20 US claimed
US-6080819-A Blends of olefin polymers and syndiotactic vinyl polymers BOREALIS AG (AT) 2000-06-27 US claimed
CN-110462715-A The manufacturing method of heat-shrinkable label, package body and heat-shrinkable label TOYO BOSEKI 2019-11-15 CN disclosed
CN-109071840-A Molding material, sheet molding compound, and fiber-reinforced composite material 三菱化学株式会社 2018-12-21 CN disclosed
CN-108794308-A 1,2,3,4- tetralin quasi-compounds and its preparation method and application 北京大学深圳研究生院 2018-11-13 CN disclosed
US-20180086684-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN ASAHI GLASS COMPANY, LIMITED (JP) 2018-03-29 US disclosed
CN-107614555-A Method for producing thermoplastic elastomer and thermoplastic elastomer 株式会社钟化 2018-01-19 CN disclosed
US-9796647-B2 Method for producing fluorine-containing olefin ASAHI GLASS COMPANY, LIMITED (JP) 2017-10-24 US disclosed
US-20170101360-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN ASAHI GLASS COMPANY, LIMITED (JP) 2017-04-13 US disclosed
US-9598335-B2 Method for producing fluorine-containing olefin ASAHI GLASS COMPANY, LIMITED (JP) 2017-03-21 US disclosed
US-20160176791-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN ASAHI GLASS COMPANY, LIMITED (JP) 2016-06-23 US disclosed
WO-2002040459-A1 PREPARATION OF MONOFLUOROALKENES BAYER CROPSCIENCE GMBH (DE) 2002-05-23 WO disclosed
US-6080819-A Blends of olefin polymers and syndiotactic vinyl polymers BOREALIS AG (AT) 2000-06-27 US disclosed
CN-1251594-A Method for producing fluoropolymer UNIV NORTH CAROLINA CHAPEL HILL (US) 2000-04-26 CN disclosed
EP-0884356-A2 Blends of polyolefins and syndiotactic vinyl polymeres PCD Polymere AG (AT) 1998-12-16 EP disclosed
US-5478964-A N-fluorosulfonimides and their application as fluorinating agents ALLIED-SIGNAL INC. (US) 1995-12-26 US disclosed
US-5326489-A Sulfonated polymer NIPPON SHOKUBAI CO., LTD. (JP) 1994-07-05 US disclosed
EP-0523300-B1 Electrorheological fluids NIPPON CATALYTIC CHEM IND (JP) 1994-01-19 EP disclosed
US-5254732-A N-fluorosulfonimides and their application as fluorinating agents ALLIED-SIGNAL INC. (US) 1993-10-19 US disclosed
EP-0523300-A1 Electrorheological fluids NIPPON SHOKUBAI KAGAKU KOGYO CO. LTD. (JP) 1993-01-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086684-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN FOS, CYP2F1, CYP4F11 ALDH1A1 607/4885TSHR 1612/4885AKR1C3 900/4885
US-20170101360-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN FOS, CYP2F1, CYP4F11 ALDH1A1 607/4885TSHR 1612/4885AKR1C3 900/4885
US-20160176791-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN FOS, CYP2F1, CYP4F11 ALDH1A1 607/4885TSHR 1612/4885AKR1C3 900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.